Alzheimer's drug lecanemab shows promise but questions remai

An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, researchers reported Tuesday – but it remains unclear how much difference that might make in people's lives.

Related Keywords

United States , Japan , San Francisco , California , Japanese , Americans , Ron Petersen , Maria Carrillo , Mayo Petersen , Madhav Thambisetty , Michael Irizarry , National Institute On , Alzheimer Association , Drug Administration , Christopher Van Dyck At Yale University , Associated Press , New England Journal , National Institute , Mayo Clinic ,